KCT0007665招募中未知
Aspirin versus clopidogrel for leaflet thrombosis prevention in patients undergoing transcatheter aortic valve replacement: ACLO-TAVR trial
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 230
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 o Limit（—）
- 性别
- All
入选标准
- •1.Patients >19 years old
- •2.Patients who underwent TAVR symptomatic severe AS
- •3.Provision of informed consent1nt
排除标准
- •1. Patients requiring dual antiplatelet therapy longer than 4 weeks
- •2. Any conditions requiring specific antiplatelet therapy aspirin or clopidogrel
- •3. History of stroke or transient ischemic attack (TIA) within 6 months
- •4. Planned major surgery
- •5. Cardiogenic shock or hemodynamic instability
- •6. Chronic kidney disease stage 4 or 5 (eGFR <30mL/min)
- •7. Valve-in-valve TAVR procedure
- •8. Hypersensitivity or contraindication to aspirin or clopidogrel
- •9. Indication for anticoagulation therapy
研究者
相似试验
进行中（未招募）
不适用
Aspirin and clopidogrel versus aspirin alone for the prevention of blood clots following transcatheter aortic valve Implantation.EUCTR2014-001675-32-ESIUCPQ300
招募中
不适用
Aspirin vs Clopidogrel After TAVRSevere Aortic StenosisNCT05493657Yonsei University270
已完成
4 期
Aspirin Versus Aspirin + ClopidogRel Following Transcatheter Aortic Valve Implantation: the ARTE TrialAortic Valve DiseaseStrokeMyocardial InfarctionNCT01559298Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec178
已完成
4 期
Aspirin Versus Aspirin+Clopidogrel as Antithrombotic Treatment Following TAVIAortic Valve DiseaseStrokeMyocardial InfarctionBleedingNCT02640794Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec222
已完成
4 期
Antiplatelet Therapy After Cardiac ArrestPostresuscitation SyndromeMyocardial Infarction (ST-Elevation Myocardial Infarction and Non-ST-Elevation Myocardial Infarction)Cardiac ArrestNCT02224274University Medical Centre Ljubljana57